<?xml version="1.0" encoding="UTF-8"?>
<p>Intraperitoneal injection of DOX to rats resulted in significant (
 <italic>p</italic> &lt; 0.05, 
 <italic>p</italic> &lt; 0.001, and 
 <italic>p</italic> &lt; 0.0001) decreased activities of SOD, CAT, GPx, GST, and GSH levels while significantly increasing (
 <italic>p</italic> &lt; 0.001) MDA activities (
 <xref rid="tab7" ref-type="table">Table 7</xref>). However, oral pretreatment with 
 <italic>IGESE</italic> significantly (
 <italic>p</italic> &lt; 0.05, 
 <italic>p</italic> &lt; 0.001, and 
 <italic>p</italic> &lt; 0.0001) attenuated the alterations in the activities of these cardiac tissue enzyme markers. Similarly, 
 <italic>IGESE</italic> pretreatment significantly (
 <italic>p</italic> &lt; 0.001 and 
 <italic>p</italic> &lt; 0.0001) and dose dependently reduced MDA levels (
 <xref rid="tab7" ref-type="table">Table 7</xref>).
</p>
